Laurus Labs Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Laurus Labs's estimated annual revenue is currently $335.7M per year.(i)
  • Laurus Labs's estimated revenue per employee is $100,500

Employee Data

  • Laurus Labs has 3340 Employees.(i)
  • Laurus Labs grew their employee count by 8% last year.

Laurus Labs's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$56.6M56321%N/AN/A
#2
$15.6M15528%N/AN/A
#3
$17M169-11%N/AN/A
#4
$13.2M1318%N/AN/A
#5
$19.6M19510%N/AN/A
#6
$23.5M2347%N/AN/A
#7
$5.3M530%N/AN/A
#8
$13M129-25%N/AN/A
#9
$20.5M20411%N/AN/A
#10
$11.7M1166%N/AN/A
Add Company

What Is Laurus Labs?

Laurus labs is an innovation-driven¸ people-centric & client-focused organization offering a broad and integrated portfolio of products & services to the global pharmaceutical industry. Equipped with a world-class infrastructure manned by best-in-class personnel & driven by the core values of knowledge, innovation and excellence, within a relatively short period, Laurus labs emerged as a segment-leading manufacturer of high quality APIs, a preferred partner for NCE development & manufacture & a trusted source of specialty ingredients for the nutraceutical industry. Given the strengths, capabilities & experience, Laurus Labs is uniquely positioned to help its clients in their endeavor of ‘quicker to market' & thus contributing towards improving access to quality & affordable healthcare worldwide.

keywords:N/A

N/A

Total Funding

3340

Number of Employees

$335.7M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Laurus Labs News

2022-04-17 - Is Laurus Labs Limited's (NSE:LAURUSLABS) Recent Stock Performance Tethered To Its Strong Fundamentals?

Laurus Labs (NSE:LAURUSLABS) has had a great run on the share market with its stock up by a significant 27% over the last three months.

2022-04-13 - Growth trajectory, margins anc client additions to sustain for Laurus Labs

With returns of over 20 per cent, Laurus Labs is by far the best performing pharmaceutical stock over the past three months.

2022-03-22 - ET Emerging Company of the Year 2021: Laurus Labs-A pharma company beats the virus trap to make it big

The company provides contract research and manufacturing services (CRAMS) to several global pharmaceutical companies, and produces specialty...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$502.7M342010%N/A
#2
$1.7M349123%N/A
#3
$1.7M3830-5%N/A
#4
$730.5M38656%N/A
#5
$7.5M387025%N/A